Ocugen plans Phase I/II trials for macular disease gene therapies
The gene therapy trials in geographic atrophy and Stargardt disease are planned to start by the end of 2023.
The gene therapy trials in geographic atrophy and Stargardt disease are planned to start by the end of 2023.
What's Your Reaction?
